Tell me blood coagulation pathway and all things involved in it and tell me about various disease that cause bleeding disorders and it correlation clinically to Ent

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Loading Image

Searching Images

coagulation cascade intrinsic extrinsic pathway factors diagram

Reading File

Loading Image

Here is a comprehensive breakdown of the blood coagulation pathway, the diseases causing bleeding disorders, and their ENT clinical correlations.

Blood Coagulation — Complete Overview

1. Overview of Hemostasis

Hemostasis — the process that arrests bleeding after vascular injury — proceeds in four sequential phases:

Vascular spasm — immediate smooth muscle contraction triggered by myogenic reflex, local autacoids, and thromboxane A2 from platelets
Platelet plug formation — primary hemostasis
Coagulation cascade — secondary hemostasis, resulting in a fibrin clot
Fibrous tissue repair — permanent sealing of the vessel

2. Platelet Plug (Primary Hemostasis)

Platelets (thrombocytes, 150,000–450,000/μL, lifespan 8–12 days, formed from megakaryocytes) become activated when vascular injury exposes subendothelial collagen:

Platelet adhesion — via von Willebrand factor (vWF) bridging collagen to platelet glycoprotein Ib (GP Ib)
Platelet activation — release of ADP, thromboxane A2, serotonin → vasoconstriction + further platelet recruitment
Platelet aggregation — GP IIb/IIIa receptors cross-link platelets via fibrinogen bridges
Platelet factor 3 (phospholipid membrane) — provides the surface for clotting reactions

3. Coagulation Cascade (Secondary Hemostasis)

The cascade is a series of zymogen → active enzyme reactions, each requiring a membrane-bound complex of: enzyme + substrate + cofactor + Ca²⁺. This confines clot formation to the injury site.

Coagulation cascade diagram showing intrinsic, extrinsic, and common pathways

A. Extrinsic Pathway (Initiation Phase)

Triggered by tissue factor (TF / Factor III) exposed after vascular injury:

Step	Event
Injury	Subendothelial TF exposed
TF + Factor VIIa	Form a complex on phospholipid surface
TF/VIIa complex	Activates Factor X → Xa AND Factor IX → IXa

This is the initiation phase. Small amounts of thrombin are generated here, but the pathway is quickly inhibited by TFPI (Tissue Factor Pathway Inhibitor).

B. Intrinsic Pathway (Amplification Phase)

Classically initiated by contact activation; physiologically acts to amplify thrombin generation:

Step	Factor Activated	Cofactors
Contact with collagen/foreign surface	XII → XIIa (+ HMWK, prekallikrein)	—
XIIa acts on	XI → XIa	HMWK
XIa acts on	IX → IXa	Ca²⁺
IXa + VIIIa + Ca²⁺ + PL	Tenase complex → X → Xa	Factor VIII (antihemophilic factor)

Factor VIII deficiency = Hemophilia A | Factor IX deficiency = Hemophilia B

C. Common Pathway (Final Phase)

Both pathways converge here:

Step	Complex / Action
Xa + Va + Ca²⁺ + PL	Prothrombinase complex
Prothrombin (II) → Thrombin (IIa)	Central enzyme of coagulation
Thrombin cleaves fibrinogen	Fibrinopeptides A & B removed → Fibrin monomers
Fibrin monomers polymerize	Form fibrin strands (weak, H-bond linked)
Factor XIII → XIIIa (activated by thrombin)	Cross-links fibrin → insoluble, stable clot

Fibrin clot formation at site of vascular injury

Positive Feedback Loops

Thrombin activates Factor V, Factor VIII, and Factor XIII — all amplify further clot formation
Thrombin activates Factor XI → further amplification via intrinsic pathway

Role of Calcium (Ca²⁺)

Ca²⁺ is required for every step except the first two (XII activation and XI activation). This is why chelating agents (citrate, oxalate, EDTA) prevent coagulation in stored blood.

Role of Vitamin K

Required by the liver for γ-carboxylation of glutamic acid residues on Factors II (prothrombin), VII, IX, X, and Protein C/S. Without this modification, these factors cannot bind Ca²⁺ and are nonfunctional.

4. Clot Dissolution (Fibrinolysis)

Once healing occurs, clot is dissolved by:

Plasmin (from plasminogen, activated by t-PA and u-PA)
Plasmin cleaves fibrin → fibrin degradation products (FDPs/D-dimers)
Regulated by PAI-1 and α₂-antiplasmin

5. Natural Anticoagulants (Control Mechanisms)

Inhibitor	Mechanism
Antithrombin III	Inhibits thrombin and Xa, IXa, XIa (heparin potentiates this)
Protein C + S	Inactivate factors Va and VIIIa
TFPI	Inhibits TF/VIIa/Xa complex
Thrombomodulin	Endothelial receptor; thrombin bound to it activates Protein C
Prostacyclin (PGI₂)	Inhibits platelet aggregation

6. Coagulation Factors Reference Table

Factor	Name	Pathway	Synthesized	Notes
I	Fibrinogen	Common	Liver	Substrate for clot
II	Prothrombin	Common	Liver (Vit K)	Cleaved to thrombin
III	Tissue factor	Extrinsic	Subendothelial	Initiates cascade
IV	Calcium (Ca²⁺)	All	—	Essential cofactor
V	Labile factor	Common	Liver	Cofactor in prothrombinase
VII	Proconvertin	Extrinsic	Liver (Vit K)	Shortest half-life
VIII	Antihemophilic factor	Intrinsic	Liver/endothelium	Deficient in Hemophilia A
IX	Christmas factor	Intrinsic	Liver (Vit K)	Deficient in Hemophilia B
X	Stuart-Prower factor	Common	Liver (Vit K)	Central convergence point
XI	Plasma thromboplastin antecedent	Intrinsic	Liver
XII	Hageman factor	Intrinsic	Liver	Contact activation
XIII	Fibrin stabilizing factor	Common	Liver/platelets	Cross-links fibrin
vWF	von Willebrand factor	—	Endothelium	Carrier for VIII; platelet adhesion

7. Diseases Causing Bleeding Disorders

A. Platelet / Primary Hemostasis Disorders

Disorder	Defect	Bleeding Pattern
Thrombocytopenia	Low platelet count (<150,000/μL)	Petechiae, purpura, mucosal bleeding, epistaxis
ITP (Immune Thrombocytopenic Purpura)	Autoantibodies destroy platelets	Petechiae, mucosal bleeding
Bernard-Soulier syndrome	Absent GP Ib → no vWF binding	Prolonged bleeding time
Glanzmann thrombasthenia	Absent GP IIb/IIIa	Failure of aggregation
Aspirin/NSAID use	COX inhibition → ↓TXA₂ → ↓aggregation	Mucosal bleeding, ↑surgical blood loss
Uremia	Qualitative platelet dysfunction	Mucosal bleeding
Myeloproliferative disorders	Abnormal platelet function	Variable

B. Coagulation Factor Deficiencies (Secondary Hemostasis Disorders)

Disorder	Factor Deficient	Pathway Affected	Inheritance	Lab
Hemophilia A	Factor VIII	Intrinsic	X-linked recessive	↑aPTT, normal PT
Hemophilia B (Christmas disease)	Factor IX	Intrinsic	X-linked recessive	↑aPTT, normal PT
Hemophilia C	Factor XI	Intrinsic	Autosomal	↑aPTT
von Willebrand disease (vWD)	vWF (± VIII)	Primary + Intrinsic	Autosomal dominant (Type 1/2), recessive (Type 3)	↑BT, ↑aPTT
Vitamin K deficiency	II, VII, IX, X	All	Acquired	↑PT + ↑aPTT
Liver disease	Multiple factors	All	Acquired	↑PT, ↑aPTT, ↓fibrinogen
DIC (Disseminated Intravascular Coagulation)	Consumption of all factors	All	Acquired	↑PT, ↑aPTT, ↑D-dimer, ↓platelets
Afibrinogenemia / Dysfibrinogenemia	Fibrinogen (Factor I)	Common	Rare	↑TT
Factor XIII deficiency	Cross-linking enzyme	Common	Rare	Normal PT/aPTT, clot dissolves in urea

C. Vascular Disorders

Disorder	Mechanism	ENT Relevance
Hereditary Hemorrhagic Telangiectasia (HHT / Osler-Weber-Rendu)	Vascular malformations	Severe, recurrent epistaxis — hallmark ENT presentation
Ehlers-Danlos syndrome	Connective tissue fragility	Mucosal bleeding, easy bruising
Scurvy (Vit C deficiency)	↓Collagen synthesis → vessel wall weakness	Gingival bleeding
Henoch-Schönlein Purpura	IgA vasculitis	Purpura, GI bleeding

8. Laboratory Tests of Coagulation

Test	Measures	Normal	Prolonged In
PT (INR)	Extrinsic + common	~12 sec / INR 1.0	Factor VII deficiency, Warfarin, liver disease, Vit K deficiency
aPTT	Intrinsic + common	25–35 sec	Hemophilia A/B/C, Heparin, lupus anticoagulant
Bleeding time	Platelet function	1–6 min	Thrombocytopenia, vWD, aspirin
Thrombin time (TT)	Fibrinogen → Fibrin	10–12 sec	Afibrinogenemia, heparin, DIC
D-dimer	Fibrinolysis/fibrin degradation	<0.5 μg/mL	DIC, PE, DVT
Platelet count	Number	150–450 × 10³/μL	Any thrombocytopenia

9. ENT Clinical Correlations of Bleeding Disorders

Epistaxis (Nosebleed) — The Most Common ENT Bleeding Presentation

Epistaxis is the sentinel ENT symptom of nearly all bleeding disorders. It arises from the highly vascular Kiesselbach's plexus (Little's area) on the anterior nasal septum.

Disorder	ENT / Clinical Correlation
von Willebrand Disease	Most common inherited cause of mucosal bleeding including epistaxis; recurrent epistaxis, especially in children and adolescents; heavy menstrual bleeding (HMB) in women
Hemophilia A/B	Less commonly presents with epistaxis, but post-tonsillectomy/adenoidectomy (T&A) hemorrhage is a serious risk; delayed bleeding (hours to days) after surgery is characteristic
Thrombocytopenia (ITP, drug-induced)	Petechiae on palate and buccal mucosa; epistaxis; gingival bleeding; ↑risk of post-operative hemorrhage
HHT (Osler-Weber-Rendu)	Recurrent, bilateral, severe epistaxis — often the presenting symptom; telangiectasias visible on nasal mucosa, lips, tongue; may require laser cautery, septodermoplasty, or embolization
Liver disease / Cirrhosis	Multiple factor deficiency → ↑surgical and post-T&A bleeding; also low platelet count due to hypersplenism
Vitamin K deficiency	Deficiency of II, VII, IX, X → prolonged PT → increased operative bleeding in ENT procedures
Aspirin / NSAID / Anticoagulant use	Among the most common causes of refractory epistaxis; must be identified pre-operatively
DIC	Mucosal oozing from multiple ENT sites; seen in sepsis, trauma — serious systemic emergency
Leukemia / Bone marrow failure	Thrombocytopenia → petechiae on palate, gingival bleeding, epistaxis; oral cavity often involved
Uremia	Platelet dysfunction → mucosal bleeding, troublesome epistaxis unresponsive to local measures; treated with DDAVP

Pre-operative ENT Assessment

Patients undergoing tonsillectomy, adenoidectomy, functional endoscopic sinus surgery (FESS), septoplasty, or rhinoplasty must be evaluated for:

History of prior excessive bleeding (tonsillectomy is a classic challenge)
Family history of bleeding
Drug history (aspirin, warfarin, NOACs, NSAIDs, herbal supplements)
Screening labs: PT, aPTT, platelet count

Patterns That Guide Diagnosis

Clinical Pattern	Likely Disorder
Petechiae + mucosal bleeding + epistaxis	Platelet disorder (thrombocytopenia, vWD)
Deep tissue hematoma + post-op delayed bleeding	Coagulation factor deficiency (Hemophilia)
Recurrent bilateral epistaxis + family history + telangiectasias	HHT
Epistaxis in child + heavy periods in mother	von Willebrand disease
Post-tonsillectomy bleeding 7–10 days later	Secondary hemorrhage (infection, eschar separation — but factor deficiency must be excluded)
Epistaxis + prolonged PT + ↑aPTT + ↓platelets + elevated D-dimer	DIC (sepsis, trauma, malignancy)

Key Summary

Pathway	Key Factors	Lab Test	Major Disease
Extrinsic	TF, VII	PT / INR	Warfarin, Vit K deficiency, liver disease
Intrinsic	XII, XI, IX, VIII	aPTT	Hemophilia A (VIII), Hemophilia B (IX)
Common	X, V, II, I, XIII	Both PT + aPTT	DIC, liver failure, afibrinogenemia
Platelet	GP Ib, GP IIb/IIIa, vWF	Bleeding time / PFA-100	vWD, ITP, Glanzmann, Bernard-Soulier

Sources: Guyton and Hall Textbook of Medical Physiology; Miller's Anesthesia 10e; Goldman-Cecil Medicine International Edition

This is a shared conversation. Sign in to Orris to start your own chat.